Metagenomi, Inc. Common Stock (MGX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.45
Day's range
$1.62

Metagenomi Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
05/15/2026 1.06 M $1.42 M   100.00% 2.81%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 787.90 K $1.06 M   25.38% 2.09%
CATALIO CAPITAL MANAGEMENT, LP 05/15/2026 528.99 K $708.85 K   0.00% 1.41%
PEAPOD LANE CAPITAL LLC 05/04/2026 516.76 K $682.92 K   3.84% 1.37%
TWO SIGMA INVESTMENTS, LP 05/15/2026 496.77 K $665.67 K   12.55% 1.32%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 395.80 K $530.37 K   0.00% 1.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2026 382.15 K $512.09 K   100.00% 1.02%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 358.20 K $480.16 K   17.09% 0.95%
PURA VIDA INVESTMENTS, LLC 05/12/2026 264.39 K $354.28 K   0.00% 0.70%
BLACKROCK, INC. 05/13/2026 230.13 K $308.38 K   2.67% 0.61%
WELLS FARGO & COMPANY/MN 05/11/2026 202.14 K $270.87 K   70.71% 0.54%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 170.17 K $228.03 K   100.00% 0.45%
MILLENNIUM MANAGEMENT LLC 05/15/2026 170.10 K $227.94 K   -27.67% 0.45%
JANE STREET GROUP, LLC 05/12/2026 151.44 K $202.93 K   -65.09% 0.40%
STATE STREET CORP 05/15/2026 120.43 K $161.37 K   0.00% 0.32%
RESOLUTE ADVISORS LLC 05/07/2026 89.94 K $120.53 K   0.00% 0.24%
MAN GROUP PLC 05/15/2026 78.64 K $105.37 K   39.19% 0.21%
NORTHERN TRUST CORP 05/14/2026 75.17 K $100.73 K   0.00% 0.20%
RBF CAPITAL, LLC 05/18/2026 64.02 K $85.79 K   0.00% 0.17%
BBR PARTNERS, LLC 05/12/2026 53.40 K $71.56 K   0.00% 0.14%
XTX TOPCO LTD 05/15/2026 40.58 K $54.38 K   -41.18% 0.11%
FORTITUDE ADVISORY GROUP L.L.C. 04/28/2026 37.19 K $49.84 K   -4.00% 0.10%
MORGAN STANLEY 05/15/2026 27.57 K $36.94 K   -53.81% 0.07%
MARSHALL WACE, LLP 05/15/2026 27.52 K $36.88 K   -65.22% 0.07%
CITADEL ADVISORS LLC 05/15/2026 16.99 K $22.77 K   -90.46% 0.05%
LPL FINANCIAL LLC 05/06/2026 16.83 K $22.56 K   49.01% 0.04%
UBS GROUP AG 05/05/2026 16.10 K $21.57 K   -35.86% 0.04%
VANGUARD GLOBAL ADVISERS, LLC 05/08/2026 13.39 K $17.95 K   100.00% 0.04%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 12.80 K $17.15 K   -7.15% 0.03%
04/22/2026 12.50 K $16.75 K   0.00% 0.03%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 11.73 K $15.71 K   -55.90% 0.03%
HRT FINANCIAL LP 05/14/2026 10.67 K $14.00 K   -3.76% 0.03%
MEEDER ASSET MANAGEMENT INC 05/07/2026 5.50 K $7.37 K   0.00% 0.01%
FMR LLC 05/15/2026 4.72 K $6.32 K   -30.70% 0.01%
US BANCORP \DE\ 05/15/2026 4.50 K $6.03 K   0.00% 0.01%
RUSSELL INVESTMENTS GROUP, LTD. 05/08/2026 4.18 K $5.60 K   -41.44% 0.01%
ADVISOR GROUP HOLDINGS, INC. 05/15/2026 2.89 K $3.87 K   0.00% 0.01%
JPMORGAN CHASE & CO 05/13/2026 1.60 K $2.02 K   0.00% 0.00%
NISA INVESTMENT ADVISORS, LLC 04/30/2026 511 $685   0.00% 0.00%
ALLWORTH FINANCIAL LP 05/15/2026 500 $670   0.00% 0.00%
JONES FINANCIAL COMPANIES LLLP 05/15/2026 500 $660   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 307 $411   0.00% 0.00%
LARSON FINANCIAL GROUP LLC 05/15/2026 50 $67   0.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 42 $56   -99.55% 0.00%
CWM, LLC 05/14/2026 25 $34   100.00% 0.00%
OPTIVER HOLDING B.V. 06/02/2026 18 $24   0.00% 0.00%
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 05/11/2026 4 $5   100.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/18/2026 0 $0   -100.00% 0.00%
BARCLAYS PLC 05/15/2026 0 $0   -100.00% 0.00%
PANAGORA ASSET MANAGEMENT INC 05/14/2026 0 $0   -100.00% 0.00%

Metagenomi Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 66 institutional investors and hedge funds held shares of Metagenomi Therapeutics Inc.. The most heavily invested institutionals were:

RENAISSANCE TECHNOLOGIES LLC: 787,900

Catalio Capital Management, LP: 528,993

Peapod Lane Capital LLC: 516,761

TWO SIGMA INVESTMENTS, LP: 496,767

BRIDGEWAY CAPITAL MANAGEMENT, LLC: 395,800

JACOBS LEVY EQUITY MANAGEMENT, INC: 382,153

17.18% of Metagenomi Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 8.28 M shares in the last 24 months. This purchase volume represents approximately $13.24 M in transactions.